Literature DB >> 8700542

Telomerase activity in human renal cell carcinoma.

C Mehle1, M A Piatyszek, B Ljungberg, J W Shay, G Roos.   

Abstract

Telomeres have a vital role in maintaining chromosome stability and are essential for long term viability. Since the very ends of linear chromosomes cannot replicate, telomeres shorten in normal somatic cells eventually resulting in growth inhibition. However, most immortal cell lines maintain stable telomeres indicating that mechanisms exist to compensate for the end replication problem. Telomerase activity, leading to synthesis of telomeric DNA repeats, has been proposed to be an important step in the immortalization process of tumor cells. In the present study, 56 renal cell carcinomas were tested for telomerase activity using the sensitive TRAP (telomeric repeat amplification protocol). Forty of the analysed tumors (71%) were positive for telomerase activity, whereas none of the 56 corresponding normal kidney samples showed telomerase activity. All telomerase negative tumors had a reduction in mean telomere restriction fragment (TRF) length and a decrease in total telomere repeat hybridization signal, though cases were observed with an increase in peak TRF lengths. No obvious association between the presence of telomerase activity and clinicopathological parameters (histopathologic grade, DNA-ploidy, stage and clinical outcome) was found. The high frequency of detection of telomerase activity in the renal cell carcinomas indicates that this enzyme is likely to be an important factor involved in the evolution of this tumor type.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8700542

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  10 in total

Review 1.  Tiptoeing to chromosome tips: facts, promises and perils of today's human telomere biology.

Authors:  J Fajkus; M Simícková; J Maláska
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2002-04-29       Impact factor: 6.237

Review 2.  Telomerase in the early detection of cancer.

Authors:  J W Shay; A F Gazdar
Journal:  J Clin Pathol       Date:  1997-02       Impact factor: 3.411

Review 3.  The telomerase cycle: normal and pathological aspects.

Authors:  Michele Brunori; Pierre Luciano; Eric Gilson; Vincent Géli
Journal:  J Mol Med (Berl)       Date:  2005-01-04       Impact factor: 4.599

4.  High telomerase activity correlates with the stabilities of genome and DNA ploidy in renal cell carcinoma.

Authors:  Hideki Izumi; Takahiko Hara; Atsunori Oga; Kenji Matsuda; Yuko Sato; Katsusuke Naito; Kohsuke Sasaki
Journal:  Neoplasia       Date:  2002 Mar-Apr       Impact factor: 5.715

5.  Telomerase activity in colorectal cancer, prognostic factor and implications in the microsatellite instability pathway.

Authors:  M Vidaurreta; M-L Maestro; S Rafael; S Veganzones; M-T Sanz-Casla; J Cerdán; M Arroyo
Journal:  World J Gastroenterol       Date:  2007-07-28       Impact factor: 5.742

6.  Telomere length and telomerase activity in malignant lymphomas at diagnosis and relapse.

Authors:  K Remes; K F Norrback; R Rosenquist; C Mehle; J Lindh; G Roos
Journal:  Br J Cancer       Date:  2000-02       Impact factor: 7.640

7.  Diagnostic usefulness of telomerase activity in nasopharyngeal carcinoma.

Authors:  C F Hwang; C Y Su; S C Kou; S C Huang; S W Leung; C M Huang; C L Cho
Journal:  Jpn J Cancer Res       Date:  2000-07

8.  A gene expression signature classifying telomerase and ALT immortalization reveals an hTERT regulatory network and suggests a mesenchymal stem cell origin for ALT.

Authors:  K Lafferty-Whyte; C J Cairney; M B Will; N Serakinci; M-G Daidone; N Zaffaroni; A Bilsland; W N Keith
Journal:  Oncogene       Date:  2009-08-17       Impact factor: 9.867

9.  Human telomerase reverse-transcriptase promoter-controlled and herpes simplex virus thymidine kinase-armed adenoviruses for renal cell carcinoma treatment.

Authors:  Dawei Tian; Yan Sun; Yang Yang; Mingde Lei; Na Ding; Ruifa Han
Journal:  Onco Targets Ther       Date:  2013-04-18       Impact factor: 4.147

10.  Coupled down-regulation of mTOR and telomerase activity during fluorouracil-induced apoptosis of hepatocarcinoma cells.

Authors:  Xinxin Bu; Fengqi Jia; Weifeng Wang; Xianling Guo; Mengchao Wu; Lixin Wei
Journal:  BMC Cancer       Date:  2007-11-12       Impact factor: 4.430

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.